Positive No.8p LNs were a poor but not an independent prognostic factor for patients with GC and should be recognized as distant metastasis.
Introduction
Gastric cancer is the second most frequent diagnosed cancer and one of the most common death-leading cancers in the world [1] [2] [3] [4] . Gastrectomy plus appropriate lymphadenectomy is the primary treatment for resectable gastric cancer. However, there remains controversy about the degree of lymph node dissection. Two European large-scale randomized controlled clinical trials failed to prove that D2 lymphadenectomy outweighed D1 lymphadenectomy [5] [6] [7] [8] , partially due to the increased postoperative morbidity, mortality, and reoperation rate without increasing survival rate. Then, further studies revealed that D2 lymphadenectomy was also associated with lower local-regional recurrence, gastric-cancer-related death, and a better survival benefit [9] [10] [11] . However, Jiang et al. conducted a meta-analysis of 12 randomized controlled trials that showed no better overall survival benefit from D2 lymphadenectomy than that of D1 lymphadenectomy [12] . Therefore, the current consensus in West countries is gastrectomy plus D1 or modified D2 lymphadenectomy for gastric cancer [2, 13] . While clinical experience from observational or randomized controlled trails in Asia demonstrated D2 lymphadenectomy could lead to better outcomes than D1 lymphadenectomy. Thus D2 lymphadenectomy is recommended as the standard procedure for resectable gastric cancer according to the treatment guideline of Japanese Gastric Cancer Association (JGCA) [14] . As for D2 lymphadenectomy plus the extraregional lymph nodes (e.g., No.13 LNs or No.16 LNs), the results of previous studies were not cogent enough because of their own limitations [15, 16] . No.8p LNs were defined as posterior lymph nodes along the common hepatic artery and also classified as the extraregional lymph nodes [17] 16) , and so forth. The principles above were applied according to Japanese Gastric Cancer Treatment Guidelines [14] . In this study, all cases underwent D1+ or D2+ lymphadenectomy plus No.8p LNs dissection.
After the dissection of suprapyloric lymph nodes, No.8a LNs were gripped in the root of arteria gastroduodenalis. The contour of the common hepatic artery was confirmed before it was barred from its initial to the proper hepatic artery. Then No.8p LNs could be dissected in vivo by the operating surgeon. The surgery related data was recorded in the advanced database of the department.
Clinicopathological Data.
The clinicopathological features contained age, gender, tumor location (longitudinal and cross-section location), histological and macroscopic type, number of harvested and metastatic lymph nodes, and tumor stage. The histological types were categorized into differentiated type and undifferentiated type. The former consisted of well, moderate, and poor differentiated adenocarcinoma, while the latter was made up of signet-ring cell carcinoma, mucinous adenocarcinoma, papillary adenocarcinoma, and undifferentiated adenocarcinoma. Tumor staging was conducted according to the tumor-node-metastasis system of Japanese Gastric Cancer Association [17] .
Follow-Up.
Patients underwent regular follow-up through outpatient visit, mails, or telephones. The last follow-up was updated to December 31st, 2014. The follow-up time ranges from 36 months to 116 months. 21 cases were lost to follow-up and the lost rate was 14.4%. Overall 3-year survival (OS) rate was evaluated in this study.
Statistical Analysis.
Continuous variables were presented as mean ± standard deviation and analyzed using with the Mann-Whitney test. Categorical data was analyzed by the means of the Chi-square test or Wilcoxon test as appropriate. The risk factors of No.8p LNs metastasis were analyzed by Rank-Sum test and Chi-square test for univariate analysis and logistic regression for multivariate analysis. OS curves of patients between subgroups were calculated by KaplanMeier method from the day of operation to the final followup or death, and differences between the survival curves were assessed by log-rank test. Cox proportional hazards model was used to identify prognostic factors in univariate and multivariate analysis. The two side's value <0.05 was considered as statistic significant. Statistical analysis was conducted by the Statistical Package for Social Science version 19.0 (SPSS, Chicago, IL, USA).
Results

Correlation Analysis between Clinicopathological Features and Metastasis of No.8p
LNs. 24 cases of 284 patients (8.5%) showed positive metastasis of No.8p LNs. Clinicopathological features of patients were analyzed between the two groups ( Table 1 ). Significant differences were found in tumor diameter ( = 0.003), mean number of metastatic lymph nodes ( = 0.000), types of gastrectomy ( = 0.042), and curative degrees ( = 0.000) owing to M1 disease, but no statistic differences were found in age ( = 0. (Table 4) . Significant difference of 3-year overall survival rates of the two groups existed in the items of gender, age gastrectomy, pathological degree, and curative degree ( < 0.050). Univariate analysis revealed that R1/R2 ( = 0.000), subtotal gastrectomy ( = 0.007), advanced T stage ( < 0.050), 
Discussion
Extent of lymph node dissection has been a decade-old argument, since D2 lymphadenectomy was recommended to be performed by experienced surgeons in West and the standard procedure in Japan [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Some of the extraregional lymph nodes had been reported [15, 16] as the extraregional lymph nodes [17] . In this study, we confirmed that metastasis rate of No.8p LNs was 8.5%, which was consistent with previous reports [18, 19] . But we failed to calculate the therapeutic index of No.8p LNs as Sasako et al. did, mainly because of the short follow-up time and relative small sample size. Hence, more high-quality and large-sample trials and long-term follow-up are necessary to assess the therapeutic index of No.8p LNs. Another characteristic, we need to notice, was the metastasis of No.8p LNs that was closely related to that of No.8a LNs compared with the other lymph nodes, tumor location. This might be in accordance with their anatomical relationship and lymphatic flow.
Patients in the No.8p+ group suffered more advanced pathological stage. Moreover, patients in the No.8p− group enjoyed better survival in the I/II/III stage than those in the No.8p+ group ( < 0.050), but patients in the No.8p− group showed no survival difference in the IV stages compared with patients in the No.8p+ group ( = 0.923). Even after R0 resection, the 3-year survival rate in No.8p+ group was much lower than that in No.8p− group ( = 0.003). Moreover, lymph node metastatic ratio had been advocated to be a more appropriate method for N stage and predicted survival partly in recent years [20, 21] . From our study, patients in the No.8p+ group had a higher lymph node metastatic ratio than that in the No.8p− negative group ( < 0.001). At pN3 stage, the lymph node metastatic ratio in the No.8p+ group was 0.446 at pN3a stage and 0.740 at pN3b stage, respectively. We also demonstrated that the 3-year survival rate in the No.8p+ group was 50.0% at pN3a stage and 8.0% at pN3b stage, respectively. Moreover, univariate analysis revealed positive No.8p LNs ( = 0.000) brought about higher risks of worse overall survival, while multivariate analysis illustrated that positive No.8p LNs was not an independent prognostic factor in GC patients. All the factors above demonstrated that No.8p LNs were extraregional lymph nodes rather than regional lymph nodes and that metastasis of No.8p LNs should be recommended as distant metastasis, which was in accordance with the Japanese Classification of Gastric Carcinoma [17] .
Conclusion
It was acknowledged that the number of cases was small in No.8p+ group. Higher rate of other M1 diseases made R0 rate less in No.8p+ group. However, survival outcomes between cases in No.8p+ group and IV stage cases in No.8p− group indicated that positive No.8p LNs was a poor but not an independent prognostic factor for patients with gastric cancer and should be recognized as the distant metastasis rather than regional lymph node metastasis.
